(NYSE: BHC) Bausch Health Companies's forecast annual revenue growth rate of -1.1% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 36.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.58%.
Bausch Health Companies's revenue in 2026 is $10,029,000,000.On average, 5 Wall Street analysts forecast BHC's revenue for 2026 to be $3,965,272,142,052, with the lowest BHC revenue forecast at $3,798,169,008,426, and the highest BHC revenue forecast at $4,189,064,365,356. On average, 4 Wall Street analysts forecast BHC's revenue for 2027 to be $3,924,515,280,192, with the lowest BHC revenue forecast at $3,732,958,029,450, and the highest BHC revenue forecast at $4,131,634,241,826.
In 2028, BHC is forecast to generate $3,546,217,498,746 in revenue, with the lowest revenue forecast at $3,231,278,111,646 and the highest revenue forecast at $3,795,204,873,018.